Neurobiological Technologies (Neurobiological Technologies) EV-to-EBIT : 0.00 (As of Jun. 06, 2024)

Neurobiological Technologies EV-to-EBIT Chart

Neurobiological Technologies Annual Data
	Trend	Jun00	Jun01	Jun02	Jun03	Jun04	Jun05	Jun06	Jun07	Jun08	Jun09
EV-to-EBIT		Get a 7-Day Free Trial					-5.84	-4.08	-3.19	-0.59	-1.61

Neurobiological Technologies Quarterly Data
	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09
EV-to-EBIT	Get a 7-Day Free Trial															-	-	-	-1.61	-0.17

Competitive Comparison of Neurobiological Technologies's EV-to-EBIT

For the Biotechnology subindustry, Neurobiological Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neurobiological Technologies's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neurobiological Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Neurobiological Technologies's EV-to-EBIT falls into.

Neurobiological Technologies EV-to-EBIT Calculation

Neurobiological Technologies's EV-to-EBIT for today is calculated as:

Neurobiological Technologies's current Enterprise Value is $0.00 Mil.
Neurobiological Technologies's EBIT for the trailing twelve months (TTM) ended in Sep. 2009 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.49 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neurobiological Technologies  (OTCPK:NTII) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Neurobiological Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2009 is calculated as:

Neurobiological Technologies's Enterprise Value for the quarter that ended in Sep. 2009 was $-2.01 Mil.
Neurobiological Technologies's EBIT for the trailing twelve months (TTM) ended in Sep. 2009 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.49 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neurobiological Technologies EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Neurobiological Technologies's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurobiological Technologies (Neurobiological Technologies) Business Description